US Patent Issued to University Of Washington on Oct. 7 for "Therapeutic nuclease compositions and methods" (Washington Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,322, issued on Oct. 7, was assigned to University Of Washington (Seattle).

"Therapeutic nuclease compositions and methods" was invented by Jeffrey A. Ledbetter (Seattle), Martha Hayden-Ledbetter (Seattle), Keith Elkon (Seattle) and Xizhang Sun (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal."

The patent was filed on March 16, 2022, under Application No. 17/696,364.

*For further information, including images, charts and tables, please visit: http://patft.uspt...